Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane channel-like protein 7 (TMC7) is part of the TMC family of predicted multi-pass membrane proteins that share similarity with ion channels. TMC7 is predicted to function as a modulator of mechanosensitive ion channels, specifically inhibiting PIEZO2 activity in dorsal root ganglion neurons, which is relevant for sensory perception of mechanical stimuli[1][4][7]. Expression studies in mice show that TMC7 is highly and specifically expressed in testicular germ cells, most abundantly in round spermatids, where it localizes to the *cis*-Golgi apparatus and is required for acrosome biogenesis; knockout models exhibit severe defects in sperm morphology and male infertility[2]. Emerging evidence suggests TMC7 may play roles in maintaining intracellular ion and pH balance and could have additional cellular functions in membrane trafficking and homeostasis[2]. Associations with certain cancers have been reported in genetic studies, but its functional significance in human disease and as a therapeutic target remains unclear[1]. No clinically approved drugs or established biomarker roles for TMC7 are known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane channel-like protein 7 (TMC7).